Patents by Inventor Ross Prestidge

Ross Prestidge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
    Patent number: 6723327
    Abstract: Methods for the prevention and treatment of disorders, including disorders of the skin and respiratory system, such as infection with mycobacteria such as M. tuberculosis or M. avium, sarcoidosis, asthma, allergic rhinitis, allergic dermatitis and lung cancers are provided, such methods comprising administering a composition comprising at least one derivative of delipidated and deglycolipidated M. vaccae cells.
    Type: Grant
    Filed: November 8, 2000
    Date of Patent: April 20, 2004
    Assignee: Genesis Research and Development Corporation
    Inventors: James D. Watson, Paul L. J. Tan, Ross Prestidge, Nevin Abernethy
  • Methods and compounds for the treatment of immunologically-mediated skin disorders
    Publication number: 20030007976
    Abstract: Methods for the treatment of skin disorders, including psoriasis, atopic dermatitis, allergic contact dermatitis, alopecia areata, skin cancers, and related disorders, such as psoriatic arthritis are provided, such methods comprising administering a composition having antigenic and/or adjuvant properties. Compositions which may be usefully employed in the inventive methods include inactivated M. vaccae cells, delipidated and deglycolipidated M. vaccae cells, M. vaccae culture filtrate and compounds present in or derived therefrom, together with combinations of such compositions.
    Type: Application
    Filed: June 13, 2001
    Publication date: January 9, 2003
    Inventors: James D. Watson, Paul L.J. Tan, Ross Prestidge
  • Compounds and methods for treatment and diagnosis of mycobacterial infections
    Patent number: 6406704
    Abstract: The present invention provides polypeptides comprising an immunogenic portion of a M. vaccae protein and DNA molecules encoding such polypeptides, together with methods for their use in the diagnosis and treatment of mycobacterial infection. Methods for enhancing the immune response to an antigen including administration of M. vaccae culture filtrate, delipidated M. vaccae cells or delipidated and deglycolipidated M. vaccae cells are also provided.
    Type: Grant
    Filed: December 4, 1998
    Date of Patent: June 18, 2002
    Assignee: Genesis Research and Development Corporation Limited
    Inventors: Paul Tan, Elizabeth Visser, Ross Prestidge, James D. Watson
  • Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
    Patent number: 6350457
    Abstract: Methods for the prevention and treatment of disorders, including disorders of the respiratory system, such as infection with mycobacteria such as M. tuberculosis or M. avium, sarcoidosis, asthma, allergic rhinitis and lung cancers are provided, such methods comprising administering a composition comprising derivatives of delipidated and deglycolipidated M vaccae cells.
    Type: Grant
    Filed: November 24, 1999
    Date of Patent: February 26, 2002
    Assignee: Genesis Research & Development Corporation Limited
    Inventors: James D. Watson, Paul L. J. Tan, Ross Prestidge
  • Methods for the treatment of immunologically-mediated skin disorders
    Patent number: 6328978
    Abstract: Methods for the treatment of skin disorders, including psoriasis, atopic dermatitis, allergic contact dermatitis, alopecia areata and skin cancers are provided, such methods comprising administering a composition having antigenic and/or adjuvant properties. Compositions which may be usefully employed in the inventive methods include inactivated M. vaccae cells, delipidated and deglycolipidated M. vaccae cells, M. vaccae culture filtrate and compounds present in or derived therefrom, together with combinations of such compositions.
    Type: Grant
    Filed: June 2, 1999
    Date of Patent: December 11, 2001
    Assignee: Genesis Research & Development Corp. Ltd.
    Inventors: James D. Watson, Paul L. J. Tan, Ross Prestidge
  • Mycobacterium vaccae antigens
    Patent number: 6001361
    Abstract: The present invention provides polypeptides comprising an immunogenic portion of a M. vaccae soluble protein and DNA molecules encoding such polypeptides, together with methods for their use in the diagnosis and treatment of mycobacterial infection. Methods for enhancing the immune response to an antigen including administration of M. vaccae culture filtrate or delipidated M. vaccae cells are also provided.
    Type: Grant
    Filed: June 12, 1997
    Date of Patent: December 14, 1999
    Assignee: Genesis Research & Development Corporation Limited
    Inventors: Paul Tan, Jun Hiyama, Elizabeth Visser, Margot Skinner, Linda Scott, Ross Prestidge
  • Compounds and methods for treatment and diagnosis of mycobacterial infections
    Patent number: 5985287
    Abstract: The present invention provides polypeptides comprising an immunogenic portion of a M. vaccae protein and DNA molecules encoding such polypeptides, together with methods for their use in the diagnosis and treatment of mycobacterial infection. Methods for enhancing the immune response to an antigen including administration of M. vaccae culture filtrate or delipidated M. vaccae cells are also provided.
    Type: Grant
    Filed: December 23, 1997
    Date of Patent: November 16, 1999
    Assignee: Genesis Research and Development Corporation Limited
    Inventors: Paul Tan, Margot Skinner, Ross Prestidge